Contrasting Amrize (NYSE:AMRZ) and Cemex (NYSE:CX)

Cemex (NYSE:CX) and Amrize (NYSE:AMRZ) are both large-cap materials companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

Risk and Volatility

Cemex has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, Amrize has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500.

Insider and Institutional Ownership

83.0% of Cemex shares are held by institutional investors. 1.0% of Cemex shares are held by insiders. Comparatively, 0.5% of Amrize shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Cemex and Amrize”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cemex	$16.13 billion	0.99	$960.00 million	$0.34	32.58
Amrize	$11.81 billion	2.19	$1.19 billion	$2.17	21.54

Amrize has lower revenue, but higher earnings than Cemex. Amrize is trading at a lower price-to-earnings ratio than Cemex, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations for Cemex and Amrize, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cemex	0	5	7	0	2.58
Amrize	2	5	9	1	2.53

Cemex currently has a consensus price target of $13.07, indicating a potential upside of 17.97%. Amrize has a consensus price target of $60.57, indicating a potential upside of 29.57%. Given Amrize’s higher possible upside, analysts plainly believe Amrize is more favorable than Cemex.

Profitability

This table compares Cemex and Amrize’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cemex	2.83%	3.82%	1.80%
Amrize	9.89%	10.17%	5.50%

Dividends

Cemex pays an annual dividend of $0.12 per share and has a dividend yield of 1.1%. Amrize pays an annual dividend of $0.44 per share and has a dividend yield of 0.9%. Cemex pays out 35.3% of its earnings in the form of a dividend. Amrize pays out 20.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Amrize beats Cemex on 10 of the 17 factors compared between the two stocks.

About Cemex

CEMEX, S.A.B. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products. It also provides crushed stone, sand, gravel, and recycled concrete products; performance materials, such as admixtures, mortars, special mortars, and asphalt; and waste management services comprising municipal and industrial, construction, demolition and excavation, and alternative raw materials. In addition, the company construction related services, including logistics and transportation, retail, pavement services, design and engineering, and others; and industrial construction products consist of precast components, 2D panels, 3D modules, and complete structures. CEMEX, S.A.B. de C.V. was founded in 1906 and is headquartered in San Pedro Garza García, Mexico.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.